BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21664725)

  • 1. [Bone metabolism changes in 100 patients with inflammatory bowel disease].
    Legido J; Gisbert JP; Maté J
    Gastroenterol Hepatol; 2011; 34(6):379-84. PubMed ID: 21664725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].
    Von Tirpitz C; Pischulti G; Klaus J; Rieber A; Brückel J; Böhm BO; Adler G; Reinshagen M
    Z Gastroenterol; 1999 Jan; 37(1):5-12. PubMed ID: 10091278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Osteoporosis and inflammatory bowel disease: prevalence and risk factors in Tunisian patients].
    Boubaker J; Feki M; Hsairi M; Fekih M; Kaabachi N; Filali A; Mebazaa A
    Gastroenterol Clin Biol; 2003 Oct; 27(10):901-7. PubMed ID: 14631305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopenia in Puerto Ricans with Crohn's disease.
    Chinea B; Rosa A; Oharriz JJ; Ramírez M; Haddock L; Pérez C; Torres EA
    P R Health Sci J; 2000 Dec; 19(4):329-33. PubMed ID: 11293884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus.
    Compeyrot-Lacassagne S; Tyrrell PN; Atenafu E; Doria AS; Stephens D; Gilday D; Silverman ED
    Arthritis Rheum; 2007 Jun; 56(6):1966-73. PubMed ID: 17530722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis.
    Bernstein CN; Seeger LL; Sayre JW; Anton PA; Artinian L; Shanahan F
    J Bone Miner Res; 1995 Feb; 10(2):250-6. PubMed ID: 7754804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Osteoporosis in inflammatory bowel disease - results of a survey among members of the German Crohn's and Ulcerative Colitis Association].
    von Tirpitz C; Steder-Neukamm U; Glas K; Sander S; Ring C; Klaus J; Reinshagen M
    Z Gastroenterol; 2003 Dec; 41(12):1145-50. PubMed ID: 14661123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Femoral neck osteopenia in patients with inflammatory bowel disease.
    Pollak RD; Karmeli F; Eliakim R; Ackerman Z; Tabb K; Rachmilewitz D
    Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of ghrelin and insulin-like growth factor binding protein-3 in the development of osteoporosis in inflammatory bowel disease.
    Koutroubakis IE; Zavos C; Damilakis J; Papadakis G; Neratzoulakis J; Karkavitsas N; Kouroumalis EA
    J Clin Gastroenterol; 2011 Jul; 45(6):e60-5. PubMed ID: 20921904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bone loss owing to inflammatory bowel disease: prospective study, 50 cases].
    Ben Hamida KS; Serghini M; Ksontini I; Kedadi H; Ben Yaghléne L; Bougassas W; Dougui MH
    Tunis Med; 2009 Feb; 87(2):144-8. PubMed ID: 19522449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skeletal morbidity in inflammatory bowel disease.
    van Hogezand RA; Hamdy NA
    Scand J Gastroenterol Suppl; 2006; (243):59-64. PubMed ID: 16782623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of risk factors for low bone mineral density in inflammatory bowel disease.
    Frei P; Fried M; Hungerbuhler V; Rammert C; Rousson V; Kullak-Ublick GA
    Digestion; 2006; 73(1):40-6. PubMed ID: 16543736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and pathogenesis of osteoporosis in patients with inflammatory bowel disease.
    Vestergaard P
    Minerva Med; 2004 Dec; 95(6):469-80. PubMed ID: 15785432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of osteopenia and osteoporosis by central and peripheral bone mineral density in men with prostate cancer during androgen-deprivation therapy.
    Bruder JM; Ma JZ; Basler JW; Welch MD
    Urology; 2006 Jan; 67(1):152-5. PubMed ID: 16413352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.
    Cazanave C; Dupon M; Lavignolle-Aurillac V; Barthe N; Lawson-Ayayi S; Mehsen N; Mercié P; Morlat P; Thiébaut R; Dabis F;
    AIDS; 2008 Jan; 22(3):395-402. PubMed ID: 18195566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mineral density in rural Thai adults living in Khon Kaen province.
    Pongchaiyakul C; Rojroongwasinkul N; Chotmongkol R; Kosulwat V; Charoenkiatkul S; Rajatanavin R
    J Med Assoc Thai; 2002 Feb; 85(2):235-44. PubMed ID: 12081125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopenia and osteoporosis in Crohn's disease: prevalence in a Dutch population-based cohort.
    Schoon EJ; van Nunen AB; Wouters RS; Stockbrügger RW; Russel MG
    Scand J Gastroenterol Suppl; 2000; (232):43-7. PubMed ID: 11232491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D levels and bone metabolism in Chinese adult patients with inflammatory bowel disease.
    Tan B; Li P; Lv H; Li Y; Wang O; Xing XP; Qian JM
    J Dig Dis; 2014 Mar; 15(3):116-23. PubMed ID: 24354597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
    Conde FA; Sarna L; Oka RK; Vredevoe DL; Rettig MB; Aronson WJ
    Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of morphometric vertebral deformities in patients with inflammatory bowel disease.
    Heijckmann AC; Huijberts MS; Schoon EJ; Geusens P; de Vries J; Menheere PP; van der Veer E; Wolffenbuttel BH; Stockbrugger RW; Dumitrescu B; Nieuwenhuijzen Kruseman AC
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):740-7. PubMed ID: 18617778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.